This review will examine PSMA expression in prostate cancer through PET-PSMA imaging, emphasizing the need for a nuanced understanding of its clinical implications and guiding future research in optimizing PSMA-targeted diagnostics and therapeutics. Here, FOLH1 is linked to prostate carcinoma.